DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
Sickle Cell Disease Association of America, Inc. Awards Community Based Organizations With $2,033,080 for Newborn Screening Follow-Up Program
The Sickle Cell Disease Association of America, Inc. (SCDAA) was awarded $2.9 million annually for the next four years from the Health Resources & Services Administration (HRSA) for the Sickle Cell Disease Newborn Screening Follow-up Program in June 2017. With these funds, SCDAA is continuing its efforts to establish the national infrastructure to ensure that individuals diagnosed with sickle cell disease (SCD) receive appropriate care coordination and follow-up services including counselling, education materials and access to a medical home.
SCDAA has identified 16 community based organizations (CBOs) in fifteen states, to receive $2,033,080, 70% of its 2017 HRSA grant award, to support them with the capacity to identify, educate and link patients to care in 15 states across America.
Related Content
-
Community CenterAyòbámi Adébáyò on how having the sickle cell trait inspired her bestselling debutIt has been quite a year for Ayòbámi A...
-
education & researchDiving into the genetics of Sickle cell diseaseIn recent years, genetics has become a h...
-
news & eventsLa Jolla Pharmaceutical company announces initiation of pivotal clinical study of LJPC-401 in patients with beta tha...La Jolla Pharmaceutical company today an...
-
education & researchSickle Cell Anemia : Modern Trends in TreatmentSickle cell disease (SCD), an inherited ...
-
videos & visualsGet Screened for Sickle Cell Traithttps://www.onescdvoice.com/wp-content/u...
-
news & eventsMARAC Advisory Statement: COVID-19 UpdateAugust 26, 2021 — The Sickle Cell Dise...
-
Community CenterScreening for sickle cell and beta thalassaemiaSickle cell and beta thalassaemi...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.